Suchergebnisse - "Personeni, Nicola"

PubPharm (136)

81

Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases

enthalten in: World journal of surgery | 2018

von Viganò, L. | Pedicini, V. | Comito, T. | +11

82

Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases

enthalten in: World journal of surgery | 2018

von Viganò, L. | Pedicini, V. | Comito, T. | +11

83

Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases

enthalten in: World Journal of Surgery | 2018

von Viganò, L. | Pedicini, V. | Comito, T. | +11

84

Regorafenib in hepatocellular carcinoma : latest evidence and clinical implications

enthalten in: Drugs in context | 2018

von Personeni, N. | Pressiani, T. | Santoro, A. | +1

85

Regorafenib for the treatment of unresectable hepatocellular carcinoma

enthalten in: Expert review of anticancer therapy | 2017

von Rimassa, L. | Pressiani, T. | Personeni, N. | +1

86

Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma : Don't Throw the Baby Out With the Bathwater!

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Personeni, N. | Rimassa, L. | Giordano, L. | +1

CommentOn: J Clin Oncol. 2017 Feb 20;35(6):622-628. - PMID 28045619

87

Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies

enthalten in: Journal of oncology practice | 2017

von Personeni, N. | Rimassa, L.

CommentOn: J Oncol Pract. 2017 Jun;13(6):356-364. - PMID 28605614

88

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy : heterogeneity-related issues and prognostic implications

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2017

von Personeni, N. | Baretti, M. | Bozzarelli, S. | +9

89

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

enthalten in: Oncotarget | 2017

von Personeni, N. | Giordano, L. | Abbadessa, G. | +15

90

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

enthalten in: Oncotarget | 2016

von Rimassa, L. | Abbadessa, G. | Personeni, N. | +17